TriSalus Life Sciences Target Price

Where could TLSI trade next? Consensus target price: $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.9

Average Target Price

$11.00

124.5% upside

1 analysts in the last 4 months

High: $11 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	H.C. WainwrightSwayampakula Ramakanth	$11	124.5% upside
2026-05-13	Lake Street	$8	63.3% upside
2024-11-15	Canaccord GenuityWilliam Plovanic	$11	124.5% upside
2024-09-16	OppenheimerSuraj Kalia	$10	104.1% upside
2024-07-02	Canaccord GenuityWilliam Plovanic	$12	144.9% upside

TriSalus Life Sciences (TLSI) FAQ

TriSalus Life Sciences's target price stands at $11. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $11 for TLSI implies 124.5% upside versus today's price ($4.9). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how TriSalus Life Sciences's target price evolved across reporting periods, while the comparison chart places TLSI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.